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Nicotine elicits several behavioural effects on mood as well as on stress and anxiety processes. Recently,
it was found that the higher order components of the sensory cortex, such as the secondary auditory
cortex Te2, are essential for the long-term storage of remote fear memories. Therefore, in the present
study, we examined the effects of acute nicotine injection into the higher order auditory cortex Te2, on
the remote emotional memories of either threat or incentive experiences in rats. We found that intra-Te2
nicotine injection decreased the fear-evoked responses to a tone previously paired with footshock. This
effect was cue- and dose-speciﬁc and was not due to any interference with auditory stimuli processing,
innate anxiety and fear processes, or with motor responses. Nicotine acts acutely in the presence of
threat stimuli but it did not determine the permanent degradation of the fear-memory trace, since
memories tested one week after nicotine injection were unaffected. Remarkably, nicotine did not affect
the memory of a similar tone that was paired to incentive stimuli. We conclude from our results that
nicotine, when acting acutely in the auditory cortex, relieves the fear charge embedded by learned
stimuli.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The pharmacological effects of nicotine e the major psychoac-
tive ingredient in tobacco smoke e are mediated by the activation
of nicotinic acetylcholine receptors (nAChRs), which are present in
several brain regions and tied to different cellular processes
(McGehee et al., 1995; Pontieri et al., 1996; Chiamulera, 2005;
Laviolette and van der Kooy, 2004; Metherate, 2004). As a conse-
quence, nicotine produces a wide variety of motivational andg-aminobutyric acid; nAChR,
c stress disorder; US, Uncon-
rtment of Neuroscience, Uni-
ly.
. Cambiaghi), anna.grosso@
nna), giulia.concina@unito.it
ti).
Ltd. This is an open access article ubehavioural effects, including acting on mood, emotions, cognition
and motor functions (Chiamulera, 2005; Laviolette and van der
Kooy, 2004; McGehee et al., 1995; Pontieri et al., 1996; Stolerman
and Jarvis, 1995; Tipps et al., 2014). Among these effects, the close
interaction between nicotine and anxiety represents one of the
main concerns, yet it is poorly understood.
Nicotine modulates the physiological responses to stress and
anxiety processes in both animal models and human smokers
(Anderson and Brunzell, 2012; Breslau, 1995; Brioni et al., 1993;
Fidler and West, 2009; File et al., 1998; George et al., 2000a,b;
George et al., 1998; Irvine et al., 2001; McGranahan et al., 2011;
Perkins and Grobe, 1992; Varani et al., 2012). Stress is also a ma-
jor precipitating factor for smoking relapse (Shiffman et al., 1997)
and for the increase in cigarette use (Skara et al., 2001). This
depiction is, however, complicated by the fact that nicotine, like
many drugs of abuse, possesses both rewarding and aversive
properties (Grieder et al., 2012; Laviolette and van der Kooy, 2003,
2004; Sun and Laviolette, 2014). Nicotine can also induce effects in
anxiety disorders such as post-traumatic stress disorder (PTSD), asnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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nicotine dependence through habitual tobacco use (Breslau et al.,
2004; Dalack et al., 1998; Hughes et al., 1986; Lasser et al., 2000;
Tipps et al., 2014; Ziedonis et al., 2008; Ziedonis and George, 1997).
In animalmodels, a useful protocol to study psychological stress,
as well as the mechanisms involved in PTSD-like manifestations, is
provided by the fear-conditioning paradigm; whereby, the subject
is exposed to a conditioned stimulus (CS), such as a tone, in asso-
ciation with an unconditioned stimulus (US), typically a footshock.
Nicotine pretreatment does not modify the acquisition or the
expression of conditioned fear-responses (George et al., 2001).
Accordingly, it was reported that the acute systemic administration
of nicotine or the direct infusion of nicotine into the dorsal hip-
pocampus did not alter fear behaviours related to a CS, but did
enhance the memory of the environment paired with the aversive
event (Davis et al., 2007; Elias et al., 2010; Kenney et al., 2012;
Raybuck and Gould, 2010; Tipps et al., 2014). Conversely, acute
nicotine injection into the ventral hippocampus produced a deﬁcit
in contextual fear memories and in trace fear conditioning (Kenney
et al., 2012; Kutlu and Gould, 2015; Gould and Leach, 2014; Raybuck
and Gould, 2010). It was therefore suggested that the effects of
nicotine vary according to the brain region (Kutlu and Gould, 2015;
Gould and Leach, 2014; Raybuck and Gould, 2010).
To our knowledge, no data are available on the effects that
nicotine induces when administered directly in brain structures
involved in the encoding of fear memories related to explicit sen-
sory cues. Recently, we found that the higher order components of
the sensory cortex, such as the secondary auditory cortex Te2, are
essential for the long-term storage of remote (i.e. 30 days) auditory
fear memories (Sacco and Sacchetti, 2010). The involvement of this
cortex is strictly related to emotional memory processes, and not is
due to any interference with sensory or innate emotional processes
(Grosso et al., 2015; Sacco and Sacchetti, 2010). Thus, this cortex is
particularly suitable for investigating the effects, if any, that nico-
tine has on explicit emotional memories, without any confounding
factors from the interference with emotional or motor processes.
Therefore, in this study, we address the question of whether, and if
so how, acute nicotine administration into Te2 can modulate the
memory of cues that are predictive of threat events.
2. Materials and methods
2.1. Subjects
Male Wistar rats (age, 65e80 days; weight, 250e350 g) were
used. The animals were housed in plastic cages with food andwater
available ad libitum, with a 12 h light/dark cycle at a constant
temperature of 22 ± 1 C. All the experiments were conducted in
accordance with the European Communities Council Directive
2010/63/EU and approved by the Italian Ministry of Health
(Authorisation No 265/2011) and by the local Bioethical Committee
of the University of Turin.
2.2. Drugs and infusion procedure
Nicotine hydrogen tartrate salt (Glentham Life Sciences, Cor-
sham, UK) was dissolved in physiological saline (0.9% NaCl) and
the pH was adjusted to 7.4. Different doses of nicotine (0.54, 27
and 54 nmol/ml; 0.6 ml per site, as calculated on the tartrate salt
weight) were applied, based on previous studies (Laviolette et al.,
2008; Sun and Laviolette, 2014) and on our preliminary experi-
ments. In particular, we applied a dose of 54 nmol/ml, as this is
similar to that of Laviolette et al. (2008) who applied a dose of
24 nmol/0.5 ml, and which has been reported to elicit rewarding
effects when injected into the ventral tegmental area (VTA)(Laviolette and van der Kooy, 2003; Paxinos and Watson, 1986).
Muscimol (Tocris Bioscience, Bristol, UK) was prepared at 1 mg/ml
in physiological saline (Letzkus et al., 2011; Martin and Ghez,
1999). The rats were infused bilaterally with either saline, nico-
tine or muscimol at a rate of 0.25 ml/min. To allow the diffusion of
the drug, the injection needle was removed after waiting for
1 min. The behavioural experiments were started at 15e20 min
after completion of the nicotine injection procedures or 60 min
after muscimol administration.
2.3. Cannulae placement
The rats were surgically implanted with bilateral, chronic,
intracranial stainless steel guide-cannulae (4 mm long, 26 gauge,
Plastic One, Roanoke, USA). First, the animals were anaesthetised
with an intraperitoneal administration of ketamine (100 mg/kg;
Ketavet; Bayer, Leverkusen, Germany) supplemented by xylazine
(5 mg/kg; Rompun; Bayer) and mounted in the stereotaxic appa-
ratus. Bilateral cannulae aimed at 2.1 mm above the Te2 cortex
were implanted at the following stereotaxic coordinates: 6.8 mm
posterior to the bregma and ±6.5 mm lateral to the midline
(Paxinos and Watson, 1986). The cannulae were lowered below the
skull surface at an angle of 19 to the vertical axis in the coronal
plane (medial to lateral). To inactivate the ventral hippocampus
adjacent to the Te2 cortex, bilateral cannulae were implanted at
2.1 mm above this structure at the following stereotaxic co-
ordinates: 6.8 mm posterior to the bregma ±4.5 mm lateral to
midline (Paxinos and Watson, 1986). The cannulae were anchored
to the skull by two anchor screws and dental cement. Once secured,
cannula dummies (Plastic One) were used to obdurate the guide
cannulae. After post-surgical recovery (8e10 days), injection
cannulae (31 gauge) were inserted through the guide cannulae. The
injector was connected through polyethylene tubing to a Hamilton
syringe (10 ml), which was mounted on an infusion pump (Harvard
Apparatus, Holliston, USA). After completing the experiments, the
cannulae placements were conﬁrmed using standard histological
methods.
2.4. The fear-conditioning paradigm
2.4.1. Fear-memory acquisition
A Skinner boxmodulewas employed as a conditioning chamber,
as in our previous work (Sacco and Sacchetti, 2010). The box ﬂoor
was made of stainless steel rods (1 cm in diameter, spaced 5 cm
apart) connected to a shock delivery apparatus. The apparatus was
enclosed within a sound attenuating chamber. Once inside, the
animals were left undisturbed for 2 min. After this time, a series of
sensory stimuli acting as CSs were administered. The ﬁnal 1 s of
each CS was accompanied with an US consisting of a scrambled
electric footshock (intensity, 0.7 mA). The rats were left in the
chamber for an additional 1min, then returned to the home cage. In
the fear conditioning to acoustic stimuli, seven pure tones (8 s,
78 dB, 3000 Hz, 22-s inter-trial interval) were delivered as CSs by a
loudspeaker located 20 cm above the grid ﬂoor. In olfactory fear
conditioning, seven almond odours (8 s, 22-s inter-trial interval)
were presented using a ﬂow-dilution olfactometer. Clean air (1.5 L/
min) was directed to a solenoid valve, which when operated,
passed the air to a 15 ml bottle containing 10 ml of almond odour.
Odourised air was then directed to the conditioning chamber via
¼-in Tygon tubing. Weaker olfactory fear memories were obtained
by employing a footshock intensity of 0.4 mA.
2.4.2. Fear-memory retention
Remote fearful memories were tested at 4 weeks after memory
acquisition. The animals were handled for three days (5 min per
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tested using a different apparatus located in a separate experi-
mental room in order to avoid conditioned fear behaviour to
contextual cues (Kim and Fanselow, 1992; Sacchetti et al., 1999,
2002, 2004; Sacco and Sacchetti, 2010). The apparatus consisted
of a plastic cagewith the ﬂoor and sides made of transparent plastic
and enclosed within a sound attenuating chamber equipped with
an exhaust fan, which eliminated odourised air from the enclosure
and provided background noise of 60 dB. Once inside, the subject
was left undisturbed for 2 min. After this time, CSs were adminis-
tered that were identical to those used during conditioning. Rat
behaviour was recorded via digital video camera. A freezing
response was taken as a fear index (Sacco and Sacchetti, 2010),
where freezing was deﬁned as the complete absence of somatic
mobility, except for respiratory movements. For each animal, the
amount of time (in seconds) spent freezing during the CSs was
measured ofﬂine. The freezing behaviour was analysed by two in-
dependent observers who were blind to the animal groups (inter-
and intra-rater reliabilities 90%). Freezing during the 120 s period
preceding the ﬁrst tone was also recorded to measure any gener-
alisation of fear (preCS period).2.5. Appetitive conditioning
2.5.1. Incentive-memory acquisition
The rats were placed on a restricted diet to maintain their body
weight at approximately 90% of their free-feeding weight. A day
before the behavioural protocol began, the rats were given ~1 g of
chocolate-ﬂavoured food pellets (Bio-Serv, F07256, Flemington,
USA) in the home cage to familiarise themwith the pellets. Animals
were conditioned in the standard Skinner box module described in
the fear-conditioning protocol (Section 2.4). The rats underwent
Pavlovian conditioning sessions in which the presentation of a CS
was coupled with an US, consisting of the delivery of one sucrose
pellet into a food cup within the chamber. The CSeUS pairing was
presented 28 times per session at variable intervals. Each condi-
tioning session lasted a total of 60 min. All the animals were
conditioned for 3 consecutive days, consisting of one conditioning
session per day.
Memory retention was tested 4 weeks post conditioning by
presenting the CSs, which were not paired with any US. To mini-
mise contextual inﬂuences, the animals were tested in an envi-
ronment completely different from that employed during the
learning trial (see Section 2.4, the fear-conditioning paradigm).
Moreover, to reduce the contribution of within-group variations in
baseline responding, we analysed the differences between the CS
responses and preCS responses (Saddoris et al., 2009). The condi-
tioned discriminative approach was calculated as the time the an-
imals spent with their head in the food cup during the ﬁrst 25 s of
CS (8 s) and post-CS presentation (17 s) minus the 25 s preceding CS
onset. The CSs were identical to those employed in the fear-
conditioning paradigm conditioning (pure tones, 8 s, 78 dB,
3000 Hz).2.6. Open-ﬁeld paradigm
In this paradigm, the rats faced a conﬂict between an innate
aversion to an open space and the motivation to explore it. A
greater amount of time spent in the brightly lit space was linked to
an index of decreased anxiety-like behaviour. The open-ﬁeld
apparatus consisted of a plastic opaque box (50  80  40 cm).
The rats were placed in the centre of the apparatus and their
behaviour was recorded for 10 min. The analyses were conducted
using the Smart 3.0 software (Panlab, Cornella, Spain).2.7. Startle analysis
The acoustic startle response was measured as an input/output
function (Valsamis and Schmid, 2011) using a startle chamber
(SPSG, La Jolla, California, USA). Startle responses were induced by
the presentation of white noise stimuli of increasing amplitude.
After an acclimation period of 5 min with a constant background
white noise of 50 dB, startle stimuli (1 s white noise) were dis-
played every 20 s, starting at 57 dB. The startle stimulus intensity
was increased between each stimulus until it reached 88 dB, thus
resulting in 10e30 trials with startle stimuli (Sacco and Sacchetti,
2010).
2.8. Histology
Following the experiments, the injected sites were histologically
veriﬁed. Rats were deeply anesthetized with intraperitoneal
administration of ketamine (100 mg/kg; Ketavet; Bayer, Leverku-
sen, Germany) supplemented by xylazine (5 mg/kg; Rompun;
Bayer) and intracardially perfused with saline, followed by 4%
formaldehyde. Brains were cut with a freezing microtome, and
injection needle tracks were identiﬁed in Nissl-stained serial sec-
tions. Subjects whose histological evidence was not adequate were
excluded from the data processing.
2.9. Statistical analysis
Student's t-tests, one-way (with the total time spent freezing or
the conditioned incentive responses as a dependent variable) and
repeated-measure (with groups as a between-subjects variable and
retention trials as a within-subjects variable) ANOVA tests and
NewmaneKeuls multiple comparisons test were employed for
comparing the different behavioural groups. Signiﬁcant differences
were reported at a P¼ 0.05 level. The degrees of freedomwere n1
throughout. The statistical analyses were performed using the SPSS
statistics 22.0 software.
3. Results
3.1. Experiment 1: nicotine injection into the Te2 cortex impairs
fearful memory retrieval
Initially, we addressed the question of whether and how nico-
tine administered locally in the Te2 cortex interferes with the
retrieval of remote fearful memories. Remote memory retention
was assessed 1 month after fear conditioning by measuring the
freezing behaviour elicited by the auditory CSs that had been pre-
viously paired with the US (Lesburgueres et al., 2011; Sacco and
Sacchetti, 2010) (Fig. 1A). To minimise contextual inﬂuences, the
rats were tested in a new environment (Kim and Fanselow, 1992;
Sacchetti et al., 1999, 2002, 2004; Sacco and Sacchetti, 2010)
(Fig. 1A).
Fig. 1B shows the total time the animals spent freezing before
the 2 min preceding and during the presentation of the seven CSs.
Freezing responses during the 2 min preceding the CS presentation
were low and similar between groups, thus indicating the absence
of generalisation phenomena (Kim and Fanselow, 1992; Sacchetti
et al., 1999). During the CS presentation, we found that nicotine
decreases the fear-evoked responses at doses of 54 (n ¼ 8) and 27
(n¼ 6) nmol/ml, while the concentration of 0.54 nmol/ml (n¼ 6) did
not modify the freezing response with reference to the saline-
injected (n ¼ 8) rats. One-way ANOVA showed a signiﬁcant dif-
ference between groups (F3,24 ¼ 24.70; P < 0.001). The subsequent
NewmaneKeuls test revealed differences between the freezing
responses of the animals injected with 54 and 27 nmol/ml doses of
Fig. 1. Nicotine-induced dose-dependent effects on remote fearful memories. (A) Schematic diagram illustrating the behavioural experiment. Saline or Nicotine at different dosages
were injected into the Te2 cortex at 15e20 min before the retention of remote auditory fear memories. (B) Fear response measured as a percentage of total immobility (freezing)
both at 2 min before (preCS) and during the overall CS presentation (CS) in saline and nicotine-injected rats at the different doses. (C) Similar results were observed by measuring
overall freezing response during CSs presentation and inter trial time intervals. (D) Total percentage of the freezing responses across the seven CS presentation in all groups. (E)
Location of the needle tips of nicotine (54 nmol/ml) in the Te2. A1, primary auditory cortex; Ent, entorhinal cortex; PRh, perirhinal cortex; Te2, secondary auditory cortex; V1 and V2,
primary and secondary visual cortices; VL, lateral ventricle. Plates are adapted from the map of Paxinos and Watson (Paxinos and Watson, 1986). The Te2 was deﬁned according to
the map of Zilles (Zilles, 1985). (F) Representative histology of the needle track in the Te2, Scale bars, 500 mm. (G) Nicotine (54 nmol/ml) did not affect conditioned freezing toward an
odour CS obtained either after strong or weaker conditioning. (H) Similar results were obtained by analysing total percentage of the freezing responses across the seven CS
presentation in all groups. *P < 0.05. All values are reported as mean ± SEM.
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not between the control group and the animals injected with
0.54 nmol/ml of nicotine (P > 0.05). Similar effects were observed by
analysing the total freezing time of the animals during CSs pre-
sentation and the inter-trial time intervals (F3,24 ¼ 9.10; P < 0.001)
(Fig. 1C).
Given that we presented seven CSs, the observed decreases in
conditioned fear behaviour may be due to an effect on the threat
memory retrieval or alternatively to an enhancement of the
extinction processes that may occur during repeated presentation
of CSs (Elias et al., 2010; Kutlu and Gould, 2015). We therefore
analysed the freezing responses during each CS presentation to test
whether the freezing response changed across trials. The ANOVA
test for the repeated measures showed differences between the
groups (F3,24 ¼ 24.72; P < 0.001), but not within each group across
the CS presentation (F3,18 ¼ 1.49; P > 0.05) (Fig. 1D). This revealed
that nicotine acts early duringmemory retrieval, i.e. during the ﬁrst
CS presentation, and similarly decreases the freezing responses to
all other CSs. A subsequent Nissl-stained inspection revealed that
intra-cortical nicotine administration did not elicit permanent
neuronal damage (Fig. 1EeF).To investigatewhether the effects of nicotinewere limited to the
neural network speciﬁcally engaged by the auditory memory pro-
cesses, we repeated the previous experiment in animals condi-
tioned to an odour CS, a process in which the Te2 is not involved
(Sacco and Sacchetti, 2010). There was no signiﬁcant difference
between saline- (n ¼ 6) and nicotine (n ¼ 6)-injected rats during
the overall CS presentation (Student's t-test, t10 ¼ 1.41, P > 0.05)
(Fig. 1G), or during each CS presentation (F1,10 ¼ 0.28; P > 0.05)
(Fig. 1H). However, the odour-conditioned animals displayed very
strong conditioned responses, potentially masking the interference
of nicotine. To rule out this possibility, nicotine administration was
repeated in rats conditioned by pairing odour CSs with lower in-
tensity USs. This procedure resulted in a weaker conditioning
(n ¼ 8) that was not affected by nicotine administration (n ¼ 8),
with regard to the overall CSs presentation (t14 ¼ 0.53, P > 0.05)
(Fig. 1G) and across each CS presentation (F1,14 ¼ 0.07; P > 0.05)
(Fig. 1H). This indicates that the nicotine effects are strictly related
to memory processes occurring in Te2 and are not secondary to
interferences from other structures, such as the amygdala or the
VTA, which are known to play a general role in emotional memory.
Furthermore, these ﬁndings show that nicotine injection into Te2
Fig. 2. Nicotine administered locally into the ventral hippocampal region adjacent to the Te2 cortex did not affect remote fear memories. (A) Location of the needle tips of nicotine
(54 nmol/ml) in the ventral hippocampus adjacent to the Te2 cortex. Plates are adapted from the map of Paxinos and Watson (Paxinos and Watson, 1986). (B) Representative
histology of the needle track in the ventral hippocampal region, Scale bars, 500 mm (CeE) Nicotine did not affected the retrieval of remote fear memories to the overall CSs
presentation (C), to the total time spent freezing during CSs presentation and intertribal intervals (D) and to each CS (E). All values are reported as mean ± SEM.
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interferes selectively with local emotional memory processes in
Te2.3.2. Experiment 2: nicotine injection into the ventral hippocampus
cortex did not hamper remote fearful memory retrieval
Several previous studies have shown that nicotine administra-
tion into the ventral hippocampus impairs contextual and trace
cued fear memories (Kenney et al., 2012; Kutlu and Gould, 2015;
Gould and Leach, 2014; Raybuck and Gould, 2010). Given that the
Te2 cortex is adjacent to the caudal portion of the ventral hippo-
campus, it may be that the nicotine effects observed in our exper-
iment are due to nicotine spreading to this region. Despite the fact
that in the aforementioned studies nicotine was administered in a
region of the ventral hippocampus far from that adjacent to the Te2
cortex, to clarify this point, we repeated the previous experiment
by injecting a similar dose of nicotine into the region of the ventral
hippocampus that is immediately adjacent to the Te2 (Figs. 2AeB).
When compared to saline-injected rats (n ¼ 7), nicotine (n ¼ 7) did
not alter remote fearful memories to CS administration (t12 ¼ 1.37,
P > 0.05) (Fig. 2C), the total freezing time during the CSs and the
inter-trial time intervals (t12 ¼ 0.12, P > 0.05) (Fig. 2D), or freezing
across each CS (F1,12 ¼ 1.05; P > 0.05) (Fig. 2E).3.3. Experiment 3: nicotine administration into the Te2 cortex did
not alter sensory, motor or emotional unconditioned responses
Nicotine has also been reported to modulate sensory stimuli
perception (Liang et al., 2008; Metherate et al., 2012). Nevertheless,
the Te2 auditory cortex is not necessary for processing simple
auditory stimuli, such as those employed in the present study with
the CSs (Sacco and Sacchetti, 2010). To better deﬁne whether intra-
Te2 nicotine administration affects auditory stimuli perception, we
analysed the auditory input/output curve by assessing the startle
responses as a function of the auditory stimulus intensity (dB)
(Valsamis and Schmid, 2011). On day 1, we measured the startle
response in the absence of any treatment (Fig. 3A). The following
day, we administered the highest effective dose of nicotine
(54 nmol//ml; n ¼ 8) or saline (n ¼ 8) (Fig. 3B). ANOVA for the
repeated measures revealed no differences between groups before
(F1,14 ¼ 0.12; P > 0.05) or after (F1,14 ¼ 0.15; P > 0.05) nicotine in-
jection (Fig. 3B). Therefore there were no signiﬁcant effects of
cortical nicotine administration on the perception and processing
of auditory stimuli.
Nicotine can enhance spontaneous motor activity and modify
innate emotional behaviour when administered systemically or in
speciﬁc brain regions, such as the VTA and the nucleus accumbens
(Ferrari et al., 2002; Panagis et al., 1996; Trigo et al., 2009). How-
ever, the Te2 cortex is neither involved in motor responses nor in
innate anxiety behaviour (Sacco and Sacchetti, 2010). The data
Fig. 3. Intra-Te2 nicotine did not affect auditory stimuli perception or motor and anxiety processes. (A) Inputeoutput auditory curve showing the average startle amplitudes in
arbitrary units (a.u.) at increased auditory stimulus intensity (dB) measured the day before (DAY 1) and after (B) nicotine (54 nmol/ml) or saline (DAY 2) injection. ANOVA for
repeated measures revealed no differences between groups before or after nicotine injection. (CeD) Representative example of saline (C) and nicotine (D)-injected rats activity
during the open-ﬁeld test. Innate fear and anxiety behaviours were similar between saline and nicotine-injected animals, as shown by the time spent (E) and the similar distance
travelled (F) in both the periphery and the centre of the arena. (GeH). Also the spontaneous motor activity was similar between saline and nicotine-treated animals, as shown by the
mean speed (G) and the total distance (H) travelled. All values are reported as mean ± SEM.
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view. However, to further rule out any possible interference of
nicotine administration in Te2 on these processes, we tested the
effects of such a manipulation on the open-ﬁeld paradigm, a well-
establishedmodel of anxiety. Nicotine (n¼ 6) or saline (n¼ 6) were
administered in the Te2 before the open-ﬁeld test (Fig. 3CeD). The
two groups did not differ in the time spent in the centre (Student'st-test, t10¼0.79, P > 0.05) or in the periphery (t10¼ 0.80, P > 0.05)
of the open ﬁeld, two measures of the innate level of anxiety
(Fig. 3E). Similarly, there were no differences in the distance trav-
elled in the centre (t10 ¼ 1.31, P > 0.05) or in the periphery
(t10 ¼ 0.2, P > 0.05) (Fig. 3F). These data support the view that the
reduction in the conditioned fear-evoked response is not due to a
change in the spontaneous fear state.
Fig. 4. Nicotine did not affect remote auditory memories to incentive stimuli. (A) Location of the needle tips of nicotine (54 nmol/ml) in Te2. A1, primary auditory cortex; Ent,
entorhinal cortex; PRh, perirhinal cortex; Te2, secondary auditory cortex; V1 and V2, primary and secondary visual cortices; VL, lateral ventricle. Plates are adapted from the map of
Paxinos and Watson (36). The Te2 was deﬁned according to the map of Zilles (Zilles, 1985). (B) Schematic diagram illustrating the behavioural experiment. Saline or Nicotine at
different doses were injected into the Te2 cortex at 15e20 min before the retention of remote auditory incentive memories. (C) The total time that the animals spent in the food cup
during the overall CSs administration minus the preCS period was the same in all behavioural groups (D) The overall food cup approach before CS presentation was similar between
all groups. (E) Schematic representation showing the Te2 inactivation through the local injection of the GABAA (g-aminobutyric acid)-receptor agonist muscimol (1.0 mg/ml) at 1 h
before remote appetitive memory recall. (F) Muscimol-injected rats showed reduced conditioned incentive responses to the CS. *P < 0.05. All values are reported as mean ± SEM.
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related to spontaneous motor activity, namely the total distance
travelled (t10 ¼ 0.71) and the averaged velocity (t10 ¼ 0.29). No
differences were detected for all instances (P > 0.05) (Fig. 3GeH).
These data conﬁrm that our manipulation did not modify the
spontaneous motor activity.
3.4. Experiment 4: investigating the intra-Te2 nicotine effects on
remote incentive memories
Our ﬁndings raised the question as to which cortical processes
are modulated by nicotine. The effects we observed could be due to
a disturbance of thememory retrieval processes occurring locally inthe Te2. Alternatively, it may be that nicotine induces a selective
decrement in the fear-evoked responses elicited by CS presenta-
tion. In addition, are these effects strictly related to threat mem-
ories or, alternatively, does nicotine also interact with emotional
memories characterised by a positive, incentive emotional content?
To investigate these issues, we tested the impact of Te2-nicotine
administration in remote emotional memories obtained by pair-
ing auditory CSs, identical to those previous employed (frequency,
amplitude and duration), with delivery of a palatable food. Remote
memories were tested 1 month after conditioning (Fig. 4AeB). The
total time that Te2-nicotine injected subjects spent with their
heads in the food cup during the presentation of CSs minus the
preCS periods did not differ at all the tested dosages (54 nmol/ml,
Fig. 5. Nicotine did not permanently affect remote fear memories. (A) Schematic diagram illustrating the behavioural procedure aimed at testing the effects of nicotine at 1 week
after its injection. (B) Rats which received saline or different doses of nicotine in Experiment 1. were subsequently tested 1 week later. No differences were detected between groups
in the conditioned freezing responses to the overall CSs. (C) Schematic diagram showing the reconsolidation procedure. (D) Percentage of freezing responses before (preCS) and
during (CS) the CS presentation is similar between control and nicotine (54 nmol/ml)-injected rats. (E) Schematic diagram showing the pre-acquisition experiment. (F) Nicotine
(54 nmol/ml) administered before acquisition trial decreased the freezing response to CSs tested one month later. (G) Similar results were observed by analysing the total time spent
freezing during both CSs presentation and the intertribal time intervals. (HeI) Total percentage of freezing responses displayed by the animals before (preCS) and during (CS) the CS
administration in the context where they were originally conditioned. All values are reported as mean ± SEM.
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injected (n ¼ 12) rats (F3,44 ¼ 1.27, P > 0.05) (Fig. 4C). No differ-
ences were detected between groups in the baseline preCSresponding (F3,44¼ 0.44, P> 0.05), thus suggesting that nicotine did
not alter motor or motivational processes (Fig. 4D). In the case of
the lowest dosage (0.54 nmol/ml), the low level of preCS responding
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vations argued against this possibility. Firstly, in the latter group the
preCS responding, even if low, is still statistically higher than zero
(Student's t-test, t11 ¼ 5.14, P < 0.001). More important, in this
group the time that animals spent in the food cup during CS pre-
sentation (51.10 ± 4.63) was similar either to that of saline-injected
rats (59.75 ± 4.10) and of the other groups that received nicotine
(54 nmol/ml, 57.79 ± 3.81; 27 nmol/ml, 50.82 ± 5.12) (F3,44 ¼ 1.24,
P > 0.05, data not shown), thus showing the lack of nicotine's ef-
fects on appetitive memories.
An alternative explanation of the present data may be that Te2 is
necessary for threat but not for incentive remote memories. To
address this issue, we tested whether blocking Te2 general activity
would impair remote appetitivememories. We thus inactivated Te2
through the local injection of the GABAA (g-aminobutyric acid)-
receptor agonist muscimol (Letzkus et al., 2011; Martin and Ghez,
1999) (Fig. 4E). When compared with the saline-injected (n ¼ 5)
animals, the muscimol-injected (n ¼ 6) rats showed a strongly
reduced conditioned incentive response to the CSs (Student's t-test,
t9¼ 5.67, P < 0.001) (Fig. 4F). These data indicate that the Te2 cortex
is necessary for the retrieval of remote appetitive memories and,
therefore, that any eventual disturbance in its activity would lead to
detrimental effects on such emotional memories.
Overall, these results show that nicotine, at all the tested doses,
did not affect incentive-memory retention, thus suggesting that
intra-Te2 nicotine injection did not elicit a speciﬁc memory
disturbance. Thus, nicotine selectively results in a decrease in
learned fear, while incentive memories remain unaffected. We
therefore conclude that acutely administered nicotine in the higher
order auditory cortex does not interfere with memory retrieval
processes at a general level, but instead, it selectively relieves the
fear aversive emotional content associated with auditory CSs.
3.5. Experiment 5: investigating the long-term effects of nicotine on
fear-memory traces
We then addressed the question of whether nicotine is only able
to reduce fearful memories acutely, or if its effects endure for a
period of time after nicotine administration. For this aim, the rats
that displayed a signiﬁcant reduction in conditioned freezing were
re-tested 1 week after nicotine injection, in a drug-free state
(Fig. 5A). The freezing responses of the nicotine-treated rats were
similar to those of the control animals (F3,24 ¼ 0.70, P > 0.05)
(Fig. 5B). The data revealed that the effects of nicotine are not long-
lasting, but are instead limited to the actual presence of nicotine in
the brain.
To further characterise the impact of nicotine on memory pro-
cesses, we investigated whether nicotine can interfere with the
memory reconsolidation processes that occur shortly after memory
retrieval. It has been shown that well-established fear memories
are altered when active compounds are applied immediately after
memory retrieval (Misanin et al., 1968; Nader et al., 2000; Sacchetti
et al., 2007; Tedesco et al., 2014), a process referred to as memory
reconsolidation (Nader et al., 2000; Schwabe and Nader, 2014;
Tedesco et al., 2014). Therefore, nicotine was administered shortly
after remote fear-memory recall. After 1 week, memory was tested
by re-presenting the CSs (Fig. 5C). No differences were detected
between the nicotine- (n ¼ 6) and saline (n ¼ 6)-injected animals
(Student's t-test, t10¼1.09, P > 0.05) (Fig. 5D), thus indicating that
nicotine did not interfere with the reconsolidation mechanisms
occurring after memory recall.
In addition, we investigated whether nicotine interferes with
the acquisition of remote memories. To this purpose, nicotine was
administered before the acquisition trial, and then memory was
tested 1 month later in a drug-free state (Fig. 5E).When comparedto saline einjected animals (n ¼ 6), rats that received nicotine
before the acquisition trial displayed a statistically signiﬁcant
decrement in the fear-evoked responses to the CSs (Student's t-test,
t10 ¼ 4.23, P < 0.05) and in the total time spent freezing during CSs
and the inter trial intervals (t10 ¼ 3.96, P < 0.05) (Fig. 5F). Taken
together with the results obtained in the Experiment 1, the data
indicate that nicotine affects either the formation and the retrieval
of remote fear memories.
So far, the datawere obtained by testingmemory in a contextual
environment that was completely different from that in which the
conditioning trials occurred. Nonetheless, as previously mentioned,
the animals that systemically received nicotine did not display any
signiﬁcant fear-relief effects when the threat memory was tested in
the same environment to which the conditioning occurred (Elias
et al., 2010; George et al., 2001). We therefore tested the impact
of nicotine administration in the Te2 on the auditory fear memories
in the context of which the animals were originally conditioned
(Fig. 5G). In this case, the presence of contextual cues determined
an elevated fear state, as indicated by the freezing of the saline- and
nicotine-injected animals during the 2 min before CS presentation
(Fig. 5H). During CS presentation, the freezing response was higher
than during the 2 min preceding it, but similar between the saline-
(n ¼ 7) and nicotine (27 nmol/ml, n ¼ 6; 54 nmol/ml, n ¼ 7)-injected
animals (F2,17 ¼ 0.31, P > 0.05) (Fig. 5I).
Collectively, these data indicate that nicotine acutely affected
the auditory fear memories when tested in a neutral environment.
This effect was strictly attributed to the presence of nicotine and
was not followed by any consequence of the original memory trace.
The data suggest that nicotine relieves the fear charge embedded
by auditory CSs but does not affect the original memory trace. This
view is further supported by the evidence that, when the fear state
of the animals was enhanced by the presence of contextual cues,
the fear-relief effect of nicotine was abolished.
4. Discussion
In this study, we have shown that acute nicotine administration
into the Te2 auditory cortex before the retrieval of remote fearful
memories decreases fear-evoked responses. This effect was cue-
and dose-speciﬁc. A similar treatment did not affect remote
incentive memories to auditory CSs previously paired with reward
stimuli. We conclude that nicotine administration in the Te2
selectively decreases the aversive charge of fear-predictive cues.
Several observations have allowed us to rule out many con-
founding factors that may have interfered with the emotional
memory processes. First, the effects of nicotine are not secondary to
any interference with innate fear and anxiety behaviour, as indi-
cated by the open-ﬁeld test and by the high level of conditioned
freezing to odour CSs. In addition, nicotine administration does not
affect auditory sensory perception and processing, as shown by the
startle reﬂex paradigm as well as by the high level of memory
retention to similar auditory CSs in appetitive-conditioned rats. We
can also rule out the possibility that intra-Te2 nicotine adminis-
tration interferes with spontaneous motor activity, thus counter-
acting the freezing response. In fact, nicotine injection did not affect
conditioned freezing to an odour CS, and it did not change the
spontaneous motor activity in the open-ﬁeld paradigm e results
which are in line with a previous study (Sacco and Sacchetti, 2010).
Nicotine's effects may be due to state-dependent effects. Although
we cannot rule out this possibility, it should be noted that nicotine
administration did not reduce auditory incentive memories or fear
conditioning to odour CSs. These data suggest that nicotine's effects
are speciﬁcally related to fear memories. Collectively, therefore, our
ﬁndings indicate that nicotine injection into the Te2 selectively
interacts with memory information encoded at the level of the
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nicotine on threat and incentive memories indicate that this drug is
not involved in simply disturbing thememory retrieval process, nor
does it affect the memory of the physical features of the tone acting
as a CS. Therefore, we suggest that nicotine, when injected into the
Te2, selectively interferes with the negative aversive valence ac-
quired by the CS.
Many studies have tested the effects of nicotine on innate
spontaneous behaviour. In rodent behavioural assays of anxiety-
like behaviour, nicotine can either decrease (Anderson and
Brunzell, 2012; File et al., 1998; McGranahan et al., 2011; Varani
et al., 2012) or promote (Cheeta et al., 2001; File et al., 1998;
Irvine et al., 2001; Ouagazzal et al., 1999; Zarrindast et al., 2008)
anxiety. Accordingly, nicotine elicits anxiolytic and stress-
dampening, in a dose- and context-dependent manner, as well as
having mood-enhancing properties in humans (Evatt and Kassel,
2010; Laje et al., 2001; Morissette et al., 2007; Picciotto, 1998).
Regarding the current ﬁndings, we found that nicotine acts directly
on the aversive emotional charge endowed in the perceived stimuli,
independently of its action on spontaneous behaviours.
Several studies have also investigated the effects of nicotine on
learned threat stimuli. The systemic administration of nicotine does
not induce any effects on learned fear obtained by pairing an
auditory stimulus to footshock, however it affects the extinction of
contextual cues and cued fear memories (Elias et al., 2010; Kutlu
and Gould, 2015; George et al., 2001; Gould and Wehner, 1999).
However, when administered systemically nicotine can cause pe-
ripheral drug-associated effects, such as a modulation of the motor
and/or sensory perception processes, as well as interacting with a
large variety of brain regions and neuronal mechanisms, producing
a complex combination of effects.
Nicotine, when administered to selected brain regions, elicits a
contextual, but not cued, fear-memory strengthening, mostly due
to an interaction with the memory and/or attentive processes that
occur in the dorsal hippocampus (Davis et al., 2007; Kenney et al.,
2012; Raybuck and Gould, 2010). Conversely, these authors also
reported that nicotine injection into the ventral hippocampus
impaired rather than potentiated contextual and trace fear mem-
ories (Kenney et al., 2012; Kutlu and Gould, 2015; Gould and Leach,
2014; Raybuck and Gould, 2010). Therefore, it is concluded that the
different behavioural effects seen with nicotine are related to
regional speciﬁcity, receptor subtype speciﬁcity and/or interactions
with diverse neurotransmitter systems (Raybuck and Gould, 2010).
In this scenario, we showed that nicotine administration in the
more posterior region of the ventral hippocampus did not affect
auditory remote fear memories, whereas nicotine injection into the
Te2 auditory cortex affected learned threat tones. The odour threat
stimuli and the conﬁguration of auditory CSs in the conditioning
environment were however unaffected, i.e. the effects of nicotine
are highly cue- and site speciﬁc.
It is worth mentioning that the doses employed in the present
study are much higher than those employed in the aforementioned
studies on the dorsal and ventral hippocampus (Davis et al., 2007;
Kenney et al., 2012; Raybuck and Gould, 2010). It may be therefore,
that the administration of lower doses in the Te2 could produce an
enhancement of the CS responses, rather than a decrease. However,
in most cases, nAChRs are formed by a combination of different
alpha and beta subunits and are highly heterogeneous across
different brain structures (Chiamulera, 2005; Laviolette and van der
Kooy, 2004; McGehee et al., 1995; Metherate et al., 2012; Pontieri
et al., 1996). Thus, memory-enhancing nicotine doses (if any) can
markedly differ between the hippocampus and the auditory cortex.
In the latter site, in the case of auditory memory enhancement
induced by intra-cortical nicotine administration, it should be also
clariﬁed as to whether these effects are due to a potentiation of thememory and/or attentive processes or rather to an improvement of
the auditory stimuli perception and processing. In fact, the systemic
administration of nicotine modulates tone-evoked responses in the
auditory cortex (Liang et al., 2008; Metherate, 2004; Metherate
et al., 2012). Future studies should therefore address these issues.
On the other hand, the doses we employed in the present study
resemble those previously employed to elicit rewarding effects on
spontaneous behaviour when nicotine was administered into the
VTA (Laviolette and van der Kooy, 2003; Sacchetti et al., 2002).
Conversely, we found that nicotine administered into the Te2 did
not increase the appetitive-conditioned responses to CSs. Given
that we used CS of strong motivational value, the effects of nicotine
on stimulus processing may be lost to ceiling effects. However, in
our study the conditioned incentive responses of the saline-treated
rats were not close to the maximum value. We therefore suggest
that the observed fear-relief effects are most likely to be due to
direct anxiolytic-like effects on threat memories. Nevertheless,
despite unlikely, we cannot ruled out the possibility that nicotine's
effects may be in part due to alteration of the motivational prop-
erties of the CSs.
We also observed an effect of nicotine on the formation of new
remote fear memories. The data therefore suggest that this sub-
stance interferes with the attribution of aversive charge to sensory
stimuli, may be though a decrease in the fear-evoked content of the
aversive experience, as we suggested during memory retrieval.
Although a large number of studies have investigated the
nAChRs in several subcortical structures, such as the VTA and the
nucleus accumbens, much less is known about how nAChRs are
formed within the auditory cortex. Several genes have been iden-
tiﬁed for a large number of receptor subunits in the cortex
(Metherate, 2004). However, most nAChRs in the sensory cortex are
thought to exist as heteromers formed by a4 and b2 subunits or as
a7 homomers (Metherate, 2004; Bieszczad et al., 2012). High-
afﬁnity nicotine binding has been detected mostly in cortical
layers 3 and 4, but also in layers 1 and 6 (Metherate, 2004). In layer
4, a4b2-containing nAChRs may be present at the presynaptic level
where they can regulate thalamo-cortical transmission (Metherate,
2004). In line with these observations, the Te2 layer 4 is reported to
be markedly activated following remote fear-memory retrieval
(Kwon et al., 2012; Sacco and Sacchetti, 2010). nAChRs have also
been detected in interneurons present in the superﬁcial layers
(Letzkus et al., 2011; Metherate, 2004). Notably, interneurons in
superﬁcial layers of the auditory cortex are involved in fear memory
(Letzkus et al., 2011; Pi et al., 2013), the activity of which is shaped
by nicotine administration (Letzkus et al., 2011).
Our ﬁndings have important implications for understanding the
interactions between nicotine and anxiety- and fear-related dis-
turbances, such as PTSD. Frequently, cigarette smokers have re-
ported that they smoke to relieve anxiety (Fidler and West, 2009;
Perkins and Grobe, 1992). Stress is also a major precipitating fac-
tor in smoking relapse (Shiffman et al., 1997) and in the escalation
of cigarette use (Skara et al., 2001). The present data support this
view, by showing that nicotine decreases fear responses associated
with perceived stimuli. Indeed, our ﬁndings have raised the
intriguing idea that nicotine can relieve fear-evoked processes
without impairing memory retrieval processes or decreasing the
subsequent fear-memory recall in the absence of nicotine.
Cigarette smoking is associated with many mental health dis-
orders. PTSD in particular has high comorbidity, with over 45% of
PTSD sufferers reported as being smokers (Breslau et al., 2004;
Dalack et al., 1998; Hughes et al., 1986; Lasser et al., 2000;
Ziedonis et al., 2008; Ziedonis and George, 1997). Moreover, the
rates of smoking are higher in individuals with PTSD than the rates
of abuse of other compounds (Breslau et al., 2004; Dalack et al.,
1998; Hughes et al., 1986; Lasser et al., 2000; Ziedonis et al.,
M. Cambiaghi et al. / Neuropharmacology 99 (2015) 577e588 5872008; Ziedonis and George, 1997). Although it does not precisely
reproduce the entire PTSD pathology, fear conditioning is widely
used to study the neural mechanisms underlying threat memories
and, therefore, to also gain novel insights into the pathophysiology
of PTSD (Taubenfeld et al., 2009; Tipps et al., 2014). In the present
study, we focused on the effects of nicotine in the retrieval phase of
memory processes, which could be similar to the mental recall/
avoidance of trauma-associated stimuli observed in PTSD-suffering
individuals. In this framework, our data suggest that individuals
with PTSD tend to use nicotine (by smoking cigarettes) as a self-
medication to relieve fear and anxiety induced by sensory cues or
intrusive memories. On the other hand, our data also showed that
threat memories are unaffected by nicotine after its use, i.e. PTSD-
like symptoms remain intact after nicotine use. It is worth
mentioning that in our study nicotine was administered locally in
the cortex and acutely in drugs-naïve animals. Indeed, nicotine has
very different effects depending on administration time course,
route and drug history. Thus, the relationship between nicotine use
and stress-related disorders requires further evaluation.
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